Moreover, it has been reported that mutations in tumors suppressor genes (TSGs) such as p16 and p53 may result in the loss of tumor-suppressor functions and the acquisition of oncogenic characteristics in multiple cancer types [52–55]. This evidence concerns the gene TP53 and neoplasm.